
zzso zzso zzso zzso are potent zzso agents for variety of cancer zzso zzso zzso acid zzso has been approved as a drug to treat zzso T cell lymphoma, and the combination of zzso and other agents have been actively tested in many clinical zzso zzso 5 early region zzso zzso has been shown to exhibit high tumor zzso activity, and gene therapy using zzso has been tested in clinical zzso Here, we showed that zzso activity of zzso was robustly enhanced by zzso in multiple cancer cells, but not in normal zzso Moreover, we showed that combination of zzso gene therapy and zzso showed high therapeutic efficacy with low toxicity in zzso zzso and breast zzso zzso zzso zzso zzso and zzso zzso zzso protein zzso whose expression was further enhanced by zzso in cancer zzso These zzso of zzso family proteins were critical for zzso induced by the combination in cancer zzso zzso enhanced zzso of zzso zzso in zzso promoter region, while zzso zzso zzso which was directly involved in zzso zzso Together, our results provide not only a novel insight into the mechanisms underlying zzso activity of zzso but also a rationale for the combined zzso and zzso gene therapy in future clinical zzso 

